Ascend Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-492,694
Closed -$15.1M 193
2017
Q1
$15.1M Buy
492,694
+63,118
+15% +$1.78M 0.68% 52
2016
Q4
$10.8M Buy
429,576
+140,953
+49% +$3.32M 0.54% 68
2016
Q3
$7.16M Sell
288,623
-94,377
-25% -$2.51M 0.44% 75
2016
Q2
$9.51M Sell
383,000
-517,000
-57% -$13.3M 0.62% 63
2016
Q1
$26M Buy
900,000
+449,920
+100% +$11.8M 2.48% 6
2015
Q4
$13.5M Buy
+450,080
New +$15.3M 0.48% 67

Other funds holding DBD

Ascend Capital's DBD Position: Q2 2017 in Review

Ascend Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2017, closing a stake of 492,694 shares — an estimated $15.1M sold.

Ascend Capital first reported a position in DBD in Q4 2015 and held it in 6 quarters. The position peaked at $26M in Q1 2016. 235 funds tracked by Wall St. Rank hold DBD as of Q2 2017.

  • Ascend Capital reported no remaining Diebold Nixdorf Incorporated position as of Q2 2017 after selling out during the quarter.
  • Ascend Capital sold 492,694 Diebold Nixdorf Incorporated shares in Q2 2017, an estimated $15.1M.
  • Ascend Capital first reported a position in Diebold Nixdorf Incorporated in Q4 2015 and held it in 6 quarters.
  • Ascend Capital's Diebold Nixdorf Incorporated position peaked at $26M in Q1 2016.
  • 235 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2017.

Based on Ascend Capital's 13F filing for Q2 2017, filed 11 Aug 2017.